meta_pixel
Tapesearch Logo
Log in
Nutrition Diva

Ozempic plateaus, muscle loss, and more

Nutrition Diva

Macmillan Holdings, LLC

Health & Fitness, Education, Arts, Nutrition, Food

4.31.7K Ratings

🗓️ 11 October 2023

⏱️ 14 minutes

🧾️ Download transcript

Summary

I want to address some headlines that I’ve seen in the past couple of weeks regarding Ozempic, the diabetes (and, now, weight loss) drug that’s already been the subject of a lot of sensational coverage this year.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello and welcome to the Nutrition Diva podcast. I'm Monica Reinegel and in this show I take

0:10.6

a closer look at nutrition headlines research and trends to help you put that information

0:16.5

into perspective and decide how or whether it may apply to you. And today I want to address

0:23.2

some headlines that I've seen over the past couple of weeks regarding ozampic. This is the

0:29.6

diabetes and now weight loss drug that's already been the subject of a lot of sensational coverage

0:36.1

this year. For example, I've seen a lot of press over a recent study showing that people who lose weight

0:42.4

on ozampic lose a fair amount of muscle mass. And another article addressed the fact that people

0:48.4

on ozampic eventually stopped losing weight and hit a plateau. Both of these news stories suggest

0:55.6

some confusion, not just about how these drugs work, but about how weight loss in general works.

1:03.5

Now before I go any further, let me clarify that I am not making a case for or against these

1:10.8

particular medications. Michael here is to add some missing perspective to some of the conversations

1:17.9

that I'm hearing and reading about this. Ozampic and WegoV are two brand names for the same

1:26.5

drug, somagletide, depending on whether it's being prescribed to treat diabetes or obesity.

1:33.5

And these are the names that you've probably been hearing a lot about lately. But somagletide

1:39.6

belongs to a larger class of medications called GLP1 agonists. And these are generally given

1:47.0

by injection. These drugs were originally developed and approved to treat type 2 diabetes and

1:54.0

they are quite effective in improving blood sugar control. But it turned out that they were also

2:01.1

quite effective in promoting weight loss. People taking these drugs can experience weight loss

2:06.6

similar to what we might see with bariatric surgery and well beyond what people who are suffering

2:13.7

from overweight or obesity are typically able to achieve with lifestyle modification alone.

2:20.8

This is not a medication that you take for a month in order to drop a dress size for your class

2:27.1

reunion or to hollow out your cheeks in preparation for your next movie role. This is not

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Macmillan Holdings, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Macmillan Holdings, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.